Global Neisseria meningitidis Infections Drug Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Neisseria meningitidis Infections Drug Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Neisseria meningitidis Infections Drug Market Overview:
Global Neisseria meningitidis Infections Drug Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Neisseria meningitidis Infections Drug involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Neisseria meningitidis Infections Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Neisseria meningitidis Infections Drug market in 2020.
Global Neisseria meningitidis Infections Drug Market Segmentation
By Type, Neisseria meningitidis Infections Drug market has been segmented into:
MGBBP-3
NCL-195
TP-10
Others
By Application, Neisseria meningitidis Infections Drug market has been segmented into:
Hospital
Clinic
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Neisseria meningitidis Infections Drug market are:
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
1. Market Overview of Neisseria meningitidis Infections Drug
1.1 Neisseria meningitidis Infections Drug Market Overview
1.1.1 Neisseria meningitidis Infections Drug Product Scope
1.1.2 Market Status and Outlook
1.2 Neisseria meningitidis Infections Drug Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Neisseria meningitidis Infections Drug Historic Market Size by Regions (2015-2020)
1.4 Neisseria meningitidis Infections Drug Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Neisseria meningitidis Infections Drug Sales Market by Type (2015-2026)
2.1 Global Neisseria meningitidis Infections Drug Historic Market Size by Type (2015-2020)
2.2 Global Neisseria meningitidis Infections Drug Forecasted Market Size by Type (2021-2026)
2.3 MGBBP-3
2.4 NCL-195
2.5 TP-10
2.6 Others
3. Covid-19 Impact Neisseria meningitidis Infections Drug Sales Market by Application (2015-2026)
3.1 Global Neisseria meningitidis Infections Drug Historic Market Size by Application (2015-2020)
3.2 Global Neisseria meningitidis Infections Drug Forecasted Market Size by Application (2021-2026)
3.3 Hospital
3.4 Clinic
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Neisseria meningitidis Infections Drug Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Neisseria meningitidis Infections Drug Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Neisseria meningitidis Infections Drug Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Neisseria meningitidis Infections Drug Business
5.1 Beijing Minhai Biotechnology Co Ltd
5.1.1 Beijing Minhai Biotechnology Co Ltd Company Profile
5.1.2 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Specification
5.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Biological E Ltd
5.2.1 Biological E Ltd Company Profile
5.2.2 Biological E Ltd Neisseria meningitidis Infections Drug Product Specification
5.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 China National Pharmaceutical Group Corp
5.3.1 China National Pharmaceutical Group Corp Company Profile
5.3.2 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Specification
5.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 GlaxoSmithKline Plc
5.4.1 GlaxoSmithKline Plc Company Profile
5.4.2 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Specification
5.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Griffith University
5.5.1 Griffith University Company Profile
5.5.2 Griffith University Neisseria meningitidis Infections Drug Product Specification
5.5.3 Griffith University Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 ImmunoBiology Ltd
5.6.1 ImmunoBiology Ltd Company Profile
5.6.2 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Specification
5.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 JN-International Medical Corp
5.7.1 JN-International Medical Corp Company Profile
5.7.2 JN-International Medical Corp Neisseria meningitidis Infections Drug Product Specification
5.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 MGB Biopharma Ltd
5.8.1 MGB Biopharma Ltd Company Profile
5.8.2 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Specification
5.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Panacea Biotec Ltd
5.9.1 Panacea Biotec Ltd Company Profile
5.9.2 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Specification
5.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Pfizer Inc
5.10.1 Pfizer Inc Company Profile
5.10.2 Pfizer Inc Neisseria meningitidis Infections Drug Product Specification
5.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Sanofi Pasteur SA
5.11.1 Sanofi Pasteur SA Company Profile
5.11.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Specification
5.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Serum Institute of India Ltd
5.12.1 Serum Institute of India Ltd Company Profile
5.12.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Specification
5.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Wellstat Vaccines LLC
5.13.1 Wellstat Vaccines LLC Company Profile
5.13.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Specification
5.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Neisseria meningitidis Infections Drug Market Size (2015-2026)
6.2 North America Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
6.3 North America Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
6.4 North America Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Neisseria meningitidis Infections Drug Market Size (2015-2026)
7.2 East Asia Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
7.3 East Asia Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
7.4 East Asia Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
8. Europe
8.1 Europe Neisseria meningitidis Infections Drug Market Size (2015-2026)
8.2 Europe Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
8.3 Europe Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
8.4 Europe Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Neisseria meningitidis Infections Drug Market Size (2015-2026)
9.2 South Asia Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
9.3 South Asia Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
9.4 South Asia Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Neisseria meningitidis Infections Drug Market Size (2015-2026)
10.2 Southeast Asia Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
10.3 Southeast Asia Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Neisseria meningitidis Infections Drug Market Size (2015-2026)
11.2 Middle East Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
11.3 Middle East Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
11.4 Middle East Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
12. Africa
12.1 Africa Neisseria meningitidis Infections Drug Market Size (2015-2026)
12.2 Africa Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
12.3 Africa Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
12.4 Africa Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Neisseria meningitidis Infections Drug Market Size (2015-2026)
13.2 Oceania Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
13.3 Oceania Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
13.4 Oceania Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
14. South America
14.1 South America Neisseria meningitidis Infections Drug Market Size (2015-2026)
14.2 South America Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
14.3 South America Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
14.4 South America Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Neisseria meningitidis Infections Drug Market Size (2015-2026)
15.2 Rest of the World Neisseria meningitidis Infections Drug Key Players in North America (2015-2020)
15.3 Rest of the World Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
15.4 Rest of the World Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
16 Neisseria meningitidis Infections Drug Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Neisseria meningitidis Infections Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|